Basics Glaukos Corporation Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Instruments and Equipment Market Cap: $5.54B Activated in VL: True Average Daily Range Avg Daily Range: $1.13 | 2.04% Avg Daily Range (30 D): $1.65 | 1.79% Avg Daily Range (90 D): $2.46 | 2.31% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): .85M Avg Daily Volume (90 D): .82M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 47 Institutional Trades Total Inst.Trades: 5,504 Avg Inst. Trade: $2.83M Avg Inst. Trade (30 D): $4.8M Avg Inst. Trade (90 D): $5.45M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.85M Avg Closing Trade (30 D): $10.46M Avg Closing Trade (90 D): $11.47M Avg Closing Volume: 56.2K         News Sep 11, 2024 @ 6:20 PM Glaukos Stocks Rides on Strong Product Demand Amid... Source: Zacks Jul 16, 2024 @ 2:30 PM Will WATCHMAN Sales Aid Boston Scientific's (BSX) ... Source: N/A Jul 16, 2024 @ 2:06 PM Truist lifts Glaukos shares target, highlights str... Source: Emilio Ghigini Jul 10, 2024 @ 1:05 PM This Visa Analyst Is No Longer Bullish; Here Are T... Source: Avi Kapoor Jul 4, 2024 @ 10:07 AM Global Ophthalmic Devices Market Analysis Report 2... Source: Researchandmarkets.Com Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.3 $-.32 $-.59 Diluted EPS $-2.3 $-.32 $-.59 Revenue $ 404.52M $ 106.66M $ 105.5M Gross Profit $ 306.44M $ 82.35M $ 76.86M Net Income / Loss $ -123.68M $ -18.15M $ -33.58M Operating Income / Loss $ -103.98M $ -20.68M $ -28.67M Cost of Revenue $ 98.09M $ 24.32M $ 28.64M Net Cash Flow $ 74.62M $ -53.52M $ 72.41M PE Ratio